Breakthrough Therapy

Meet two of the scientists behind the game-changing gene therapies created by the Research Institute's Clinical Vector Core.

An infographic and article look at the science behind gene therapy, challenges faced by the field, and the road ahead.

It was a pivotal moment that has turned into a new era for cancer immunotherapy. On April 17, 2012, Children's Hospital of Philadelphia researchers for the first time treated a pediatric patient with a cellular therapy that used her own reprogrammed immune cells, called T cells, to attack her aggressive form of blood cancer.